BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2014 10:14:00 AM | Browse: 1164 | Download: 977
Publication Name World Journal of Gastroenterology
Manuscript ID 3869
Country/Territory Cuba
Received
2013-05-29 09:17
Peer-Review Started
2013-05-29 15:45
To Make the First Decision
2013-07-05 18:41
Return for Revision
2013-07-14 19:00
Revised
2013-08-22 04:54
Second Decision
2013-09-05 11:20
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-09-05 12:52
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-01-24 21:34
Publish the Manuscript Online
2014-02-17 14:01
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Autobiography
Article Title Recombinant streptokinase vs phenylephrine-based suppositories in acute hemorrhoids, randomized, controlled trial (THERESA-3)
Manuscript Source Invited Manuscript
All Author List Francisco Hernández-Bernal, Georgina Castellanos-Sierra, Carmen M Valenzuela-Silva, Karem M Catasús-Álvarez, Roselin Valle-Cabrera, Ana Aguilera-Barreto and Pedro A López-Saura; the THERESA-3 Group of Investigators
Funding Agency and Grant Number
Funding Agency Grant Number
Heber Biotec, Havana
Ministry of Public Health of Cuba
Corresponding Author Dr. Francisco Hernández-Bernal, Center for Genetic Engineering and Biotechnology, PO Box 6162, Havana 10600, Cuba. hernandez.bernal@cigb.edu.cu
Key Words Streptokinase; Suppository; Phenylephrine; Thrombolysis; Hemorrhoids; Randomized clinical trial
Core Tip Medical treatments for acute hemorrhoidal disease come very seldom from randomized, controlled clinical trials. The paper describes that a candidate to a new therapeutic alternative, based on thrombolysis, shows significant efficacy advantage with respect to a widely used, over-the-counter, hemorrhoidal product.
Publish Date 2014-02-17 14:01
Citation Hernández-Bernal F, Castellanos-Sierra G, Valenzuela-Silva CM, Catasús-álvarez KM, Valle-Cabrera R, Aguilera-Barreto A, López-Saura PA; the THERESA-3 Group of Investigators. Recombinant streptokinase vs phenylephrine-based suppositories in acute hemorrhoids, randomized, controlled trial (THERESA-3). World J Gastroenterol 2014; 20(6): 1594-1601
URL http://www.wjgnet.com/1007-9327/full/v20/i6/1594.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i6.1594
Full Article (PDF) WJG-20-1594.pdf
Full Article (Word) WJG-20-1594.doc
Manuscript File 3869-Review.doc
Answering Reviewers 3869-Answering reviewers.pdf
Copyright License Agreement 3869-Copyright assignment.PDF
Non-Native Speakers of English Editing Certificate 3869-Language certificate.pdf
Peer-review Report 3869-Peer reviews.pdf
Scientific Editor Work List 3869-Scientific editor work list.doc